ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity

Ou, Junxian; Zhou, Zhonghua; Dai, Ruixue; Zhang, Jing; Zhao, Shan; Wu, Xiaowei; Lan, Wendong; Ren, Yi; Cui, Lilian; Lan, Qiaoshuai; Lu, Lu; Seto, Donald; Chodosh, James; Wu, Jianguo; Zhang, Gong*; Zhang, Qiwei*复旦大学; 南方医科大学; 河北医科大学; 中国医学科学院
Journal of Virology2021-8DOI: 10.1128/JVI.00617-21
62被引6阅读
引用收藏
分享

摘要

The current pandemic of COVID-19 is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 spike protein receptor-binding domain (RBD) is the critical determinant of viral tropism and infectivity. To investigate whether naturally occurring RBD mutations during the early transmission phase have altered the receptor binding affinity and infectivity, we first analyzed in silico the binding dynamics between SARS-CoV-2 RBD mutants and the human angiotensin-converting enzyme 2 (ACE2) receptor. Among 32,123 genomes of SARS-CoV-2 isolates (December 2019 through March 2020), 302 nonsynonymous RBD mutants were identified and clustered into 96 mutant types. The six dominant muta-tions were analyzed applying molecular dynamics simulations (MDS). The mutant type V367F continuously circulating worldwide displayed higher binding affinity to human ACE2 due to the enhanced structural stabilization of the RBD beta-sheet scaffold. The MDS also indicated that it would be difficult for bat SARS-like CoV to infect humans. However, the pangolin CoV is potentially infectious to humans. The increased infectivity of V367 mutants was further validated by performing receptor-ligand binding enzyme-linked immunosorbent assay (ELISA), surface plasmon resonance, and pseudotyped vi-rus assays. Phylogenetic analysis of the genomes of V367F mutants showed that during the early transmission phase, most V367F mutants clustered more closely with the SARS-CoV-2 prototype strain than the dual-mutation variants (V367F1D614G), which may derivate from recombination. The analysis of critical RBD mutations provides fur-ther insights into the evolutionary trajectory of early SARS-CoV-2 variants of zoonotic origin under negative selection pressure and supports the continuing surveillance of spike mutations to aid in the development of new COVID-19 drugs and vaccines. @@@ IMPORTANCE A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused the pandemic of COVID-19. The origin of SARS-CoV-2 was associated with zoonotic infections. The spike protein receptor-binding domain (RBD) is identified as the critical determinant of viral tropism and infectivity. Thus, whether mutations in the RBD of the circulating SARS-CoV-2 isolates have altered the receptor binding affinity and made them more infectious has been the research hot spot. Given that SARS-CoV-2 is a novel coronavirus, the significance of our research is in identifying and validating the RBD mutant types emerging during the early transmission phase and increasing human angiotensin-converting enzyme 2 (ACE2) receptor binding affinity and infectivity. Our study provides insights into the evolutionary trajectory of early SARS-CoV-2 variants of zoonotic origin. The continuing surveillance of RBD mutations with increased human ACE2 affinity in human or other animals is critical to the development of new COVID-19 drugs and vaccines against these variants during the sustained COVID-19 pandemic.

学科与关键词

关键词
COVID-19SARS-CoV-2receptor-binding domain (RBD)viral infectivityACE2 receptorvariantsmutation
相关
加载中…
  • Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study
    Khan, Abbas; Hussain, Sarfaraz; Ahmad, Sajjad; Suleman, Muhammad; Bukhari, Imrana; Khan, Taimoor; Rashid, Farooq; Azad, Abul Kalam; Waseem, Muhammad; Khan, Wajid; Hussain, Zahid; Khan, Asghar; Ali, Syed Shujait; Qin, Qiyao; Wei, Dong-Qing*Computers in Biology and Medicine, 2022, 141: 105163.被引 13
  • Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
    Han, Pengcheng; Li, Linjie; Liu, Sheng; Wang, Qisheng; Zhang, Di; Xu, Zepeng; Han, Pu; Li, Xiaomei; Peng, Qi; Su, Chao; Huang, Baihan; Li, Dedong; Zhang, Rong; Tian, Mingxiong; Fu, Lutang; Gao, Yuanzhu; Zhao, Xin; Liu, Kefang; Qi, Jianxun*; Gao, George F.*; Wang, Peiyi*Cell, 2022, 185(4): 630-+.被引 260
  • Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
    Su, Chao; He, Juanhua; Han, Pengcheng; Bai, Bin; Li, Dedong; Cao, Jian; Tian, Mingxiong; Hu, Yu; Zheng, Anqi; Niu, Sheng; Chen, Qian; Rong, Xiaoyu; Zhang, Yanfang; Li, Weiwei; Qi, Jianxun; Zhao, Xin; Yang, Mengsu*; Wang, Qihui*; Gao, George Fu*Journal of Virology, 2022, 96(17).被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Virology
发表日期
2021-08
卷期
第 95 卷, 第 16 期
页码
e00617-21
DOI
10.1128/JVI.00617-21
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2017YFA0505001/2018YFC0910200/2018YFE0204503]; National Natural Science Foundation of China [81730061]; Guangdong Key Research and Development Program [2019B020226001]; Natural Science Foundation of Guangdong Province [2021A1515010788, 2018B030312010]; Guangzhou Healthcare Collaborative Innovation Major Project [201803040004, 201803040007]

作者

  • O

    Ou, Junxian (第一作者)

    southern med univ

  • Z

    Zhou, Zhonghua

查看全部 16 位作者收起作者
  • D

    Dai, Ruixue

    fudan univ

  • Z

    Zhang, Jing

    inst med

  • Z

    Zhao, Shan

    southern med univ

  • W

    Wu, Xiaowei

    southern med univ

  • L

    Lan, Wendong

    southern med univ

  • R

    Ren, Yi

    inst med

  • C

    Cui, Lilian

  • L

    Lan, Qiaoshuai

    cams · fudan univ

  • L

    Lu, Lu

    cams · fudan univ

  • S

    Seto, Donald

  • C

    Chodosh, James

  • W

    Wu, Jianguo

    inst med

  • Z

    Zhang, Gong (通讯)

  • Z

    Zhang, Qiwei (通讯)

    southern med univ · inst med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417